BioLife Solutions, Inc.
BLFSNASDAQHealthcareMedical Instruments & Supplies
As of Oct 7, 2026 close
- Market cap
- $1.90B
- P/E (TTM)
- 37.73
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $17.86$39.76
- Volume (live)
- -
- Avg. volume (3M)
- 1.05M
BLFS was delisted on Oct 24, 2026. Data shown is historical and no longer updated.
BioLife Solutions (BLFS) Stock Price & Financial Analysis
BioLife Solutions Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $38.61 - $38.61 |
|---|---|
| 52-Week High | $39.76 |
| 52-Week Low | $17.86 |
| Open | $38.61 |
| Average Volume (3M) | 1.05M |
| Revenue (TTM) | 102.82M |
|---|---|
| Net Income (TTM) | 50.45M |
| Free Cash Flow (TTM) | -2.11M |
| EPS (TTM) | $1.03 |
| Profit Margin | 49.06% |
| Operating Margin | 7.25% |
| Return on Equity (ROE) | 12.01% |
| Debt to Equity | 0.04 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Market Cap | 1.90B |
|---|---|
| Shares Outstanding | 49.29M |
| P/E Ratio (TTM) | 37.73 |
| Price to Sales (P/S) | 18.51 |
| Price to Book (P/B) | 4.53 |
| EV/EBITDA | 202.13 |
| 50-Day MA | $36.00 |
|---|---|
| 200-Day MA | $26.76 |
| 1-Year Change | +34.72% |
Source: Market prices and company fundamentals. Data as of Oct 7, 2026. Data sources and methodology
BioLife Solutions at a Glance
As of the Oct 7, 2026 close, BioLife Solutions (BLFS) has a market capitalization of $1.90B. The stock trades at 37.7× trailing earnings and 18.5× sales. Over the trailing twelve months it earned $50.45M on revenue of $102.82M (a 49.1% profit margin) and burned $2.11M of free cash flow. Revenue grew 62.0% year over year.
As of its latest reported balance sheet, it holds $24.00M in cash and securities against $15.74M of debt, a net cash position of $8.26M.
BioLife Solutions does not currently pay a dividend.
The share price is up 34.7% over the past year. At $38.61 (the Oct 7, 2026 close) it sits near the top of its 52-week range of $17.86 to $39.76, above its 200-day moving average of $26.76.
Based on 4 professional analyst ratings from the past 90 days, the consensus is Hold with an average price target of $31.00, 19.7% below the Oct 7, 2026 close.
Frequently Asked Questions About BioLife Solutions
What is the current stock price for BLFS?
As of the Oct 7, 2026 close, BLFS stock trades at $38.61. The 52-week range is $17.86–$39.76, with a day range of $38.61–$38.61.
What is the P/E ratio for BLFS?
As of the Oct 7, 2026 close, BioLife Solutions's trailing twelve-month (TTM) P/E ratio is 37.7, meaning investors pay $37.7 for every $1 of annual earnings. BioLife Solutions operates in the Healthcare sector.
Does BLFS pay dividends?
BioLife Solutions does not currently pay a regular dividend. The company retains its earnings to reinvest in the business. Check the Dividends tab for historical dividend information.
What do analysts recommend for BLFS?
Based on ratings from 4 professional analysts over the last 90 days, the consensus for BLFS is Hold. The average 12-month price target is $31.00, a 19.7% downside from the Oct 7, 2026 close of $38.61.
What is the market cap of BLFS?
As of the Oct 7, 2026 close, BioLife Solutions's market capitalization is $1.90B, classifying it as a small-cap company. BioLife Solutions operates in the Healthcare sector within the Medical Instruments & Supplies industry.